ISTANBUL, April 1 (Reuters) - An initial investigation into the Turkish unit of Swiss drugmaker Novartis over allegations it benefitted from bribery has not revealed any problems, a senior official for Turkey's health ministry said on Friday.
Read more
No comments:
Post a Comment